MyoPharm

MyoPharm is a leading biotechnology company dedicated to providing pharmaceutical companies with advanced solutions for pre-clinical compound analysis. Through proven-effective methods, MyoPharm offers a significant cost-cutting opportunity and lowers attrition risk during the clinical trial stage. The company specializes in innovative 3D-bioprinting technology to develop organs-on-chip for compound screening and tissue engineering.

Located at 2 Simcoe Street South, Suite 300, Oshawa, CA, MyoPharm is committed to developing prototypes of organ tissues for further product testing, development, and market commercialization. MyoPharm's groundbreaking work aims to revolutionize drug discovery and development processes, ensuring more efficient and reliable outcomes for its partners.

MyoPharm continues to push the boundaries of biotechnology research, contributing to advancements in healthcare and pharmaceutical innovation. We invite the manager of MyoPharm to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to the industry.